537  0 Kommentare Actelion's Annual General Meeting of Shareholders held in Basel, Switzerland - All Board proposals approved

ALLSCHWIL/BASEL, SWITZERLAND - 08 May 2015 - At today's Annual General Meeting (AGM) of Actelion Ltd (SIX: ATLN), held in Basel, Switzerland, shareholders voted in favor of all proposals by the Board of Directors with a significant majority.

The meeting was attended by 249 shareholders. A total of 66'512'248 shares, or 58.28% of the total outstanding shares, was represented.

Led by the Chairman of the Board, Jean-Pierre Garnier, the company presented a review of the 2014 performance. Highlights included the outstanding financial results, the highly successful launch of Opsumit^®, the sustained demand for key products such as Tracleer^® and Veletri^®, the excellent Phase III results for selexipag studies in patients with pulmonary arterial hypertension, and the progress made with the company's clinical development pipeline. The Chairman highlighted that Actelion - once again - created substantial value in 2014, with a total shareholder return of 55%.

The shareholders approved the Annual Report 2014 as well as the Statutory and the Consolidated Financial Statements 2014.

A proposal by the Board to distribute as dividend out of legal reserve originating from capital contribution in the amount of CHF 1.30 per registered share was passed by shareholders. The ex-dividend date will be 12 May 2015 and the payment will be made on 15 May 2015.

Shareholders endorsed the 2014 compensation report by way of consultative vote.

Shareholders also approved the aggregate maximum compensation for the Board of Directors (Non-Executive Directors) for the term until the AGM 2016 and the aggregate compensation amount for the Actelion Executive Committee (AEC) for the financial year 2016.

Jean-Pierre Garnier, Chairman of the Board of Directors, commented: "2014 was an outstanding year for Actelion. I would like to thank shareholders for their confidence in Actelion and their votes in favor of all the Board's proposals. This was the first time the shareholders were asked to approve Actelion's compensation proposals in accordance to the Articles of Incorporation amended in 2014. I am encouraged by the resounding support that our proposals received."